# POST-E1 Behavioral Effectiveness & Efficiency Hardening

Status: **COMPLETE / PRODUCT-VALUE DECISION RECORDED**  
Tracking issue: [#22](https://github.com/Habib1001-m/hakim/issues/22)  
Final T08 decision: `PROCEED_TO_BOUNDED_EXTERNAL_EVALUATION`  
Evaluator campaign start: **NOT AUTHORIZED NOW**

## Phase outcome

POST-E1 was opened because the first controlled production-like A/B experiment showed that Hakim changed engineering behavior but did not yet prove that the change was materially better or acceptably efficient.

The phase is now complete. T01-T05 hardened the behavioral contract and runtime salience, T06 established repeated positive internal controlled value across three task classes, T07 reconciled the alarming E2 latency outlier without finding an evidence-backed product defect, and T08 recorded the explicit product-value decision.

The final phase decision is:

`POST_E1_PHASE_DECISION = COMPLETE`

The final product-value decision is:

`T08_D_DECISION = PROCEED_TO_BOUNDED_EXTERNAL_EVALUATION`

This does **not** start an evaluator campaign. The operator explicitly directed at closure:

`EVALUATOR_CAMPAIGN_START = NOT_AUTHORIZED_NOW`

Stable `1.0.0`, release publication, broad recruitment, registry publication, marketplace promotion, and universal product/performance claims remain unauthorized.

## Final taskboard

- [x] **T01 — Pre-mutation baseline discipline** ([#24](https://github.com/Habib1001-m/hakim/issues/24)) — contract and runtime behavior completed; corrected E2, E3, and E4 Treatment traces established representative baseline-before-mutation and skill-before-mutation.
- [x] **T02 — Evidence sufficiency / stop-inspecting discipline** ([#25](https://github.com/Habib1001-m/hakim/issues/25)) — bounded stopping semantics implemented; runtime evidence is positive, while exact inspection sufficiency remains deliberately bounded as a future real-user question.
- [x] **T03 — Domain-guard preservation** ([#26](https://github.com/Habib1001-m/hakim/issues/26)) — real domain/security/privacy/integrity/accessibility/trust invariants protected by contract and preserved in accepted controlled scenarios.
- [x] **T04 — Outcome-oriented restraint** ([#27](https://github.com/Habib1001-m/hakim/issues/27)) — smallest means sufficient/coherent/safe rather than minimum LOC/files.
- [x] **T05 — Behavioral regression coverage** ([#28](https://github.com/Habib1001-m/hakim/issues/28)) — deterministic semantic coverage plus real structured-trace runtime checking implemented and CI-protected.
- [x] **T06 — Repeated controlled experiments** ([#29](https://github.com/Habib1001-m/hakim/issues/29)) — **PASS**. Corrected E2 plus E3/E4 produced 3/3 `TREATMENT_ADVANTAGE`, no accepted functional regression, median elapsed overhead `+3.21%`, and median tool-call delta `-29.17%`. Ledger: [`T06_ACCEPTANCE.md`](../experiments/post-e1/T06_ACCEPTANCE.md).
- [x] **T07 — Efficiency reconciliation** ([#30](https://github.com/Habib1001-m/hakim/issues/30)) — **COMPLETE** with `EFFICIENCY_RECONCILED_NO_CHANGE`. The original E2 `+73.15%` debit was causally unidentifiable and failed counterbalanced replication, which produced approximately `+0.008%` / `+7ms` elapsed delta and `-45%` Treatment tool calls. Ledger: [`T07_ACCEPTANCE.md`](../experiments/post-e1/T07_ACCEPTANCE.md).
- [x] **T08 — Product-value decision** ([#31](https://github.com/Habib1001-m/hakim/issues/31)) — **COMPLETE** with `PROCEED_TO_BOUNDED_EXTERNAL_EVALUATION`. Review: [`T08_PRODUCT_VALUE_REVIEW.md`](../experiments/post-e1/T08_PRODUCT_VALUE_REVIEW.md). Acceptance: [`T08_ACCEPTANCE.md`](../experiments/post-e1/T08_ACCEPTANCE.md).

## Designed outcome

Hakim should cause a coding agent to make the **smallest sufficient, coherent, safe change** after obtaining enough repository evidence to understand the task, while preserving real domain guards and validating the result with evidence proportional to the risk.

The intended working sequence is:

```text
inspect
  -> establish a runnable pre-change baseline when reasonably available
  -> stop inspecting once evidence is sufficient
  -> choose the smallest sufficient safe change
  -> preserve domain/security/privacy/integrity/accessibility/trust guards
  -> implement
  -> validate proportionally
  -> report only what the evidence supports
```

`Smallest` does not mean minimum line count. A slightly larger coherent change can be safer and more maintainable than a smaller but incomplete one.

## E1 truth preserved

POST-E1 does not rewrite the first experiment.

### Demonstrated E1 positive signals

- Hakim activation produced an observable change in agent behavior.
- Repository inspection depth increased.
- Product-state handling improved in at least one concrete user-facing path.
- Saved-workspace UX was integrated into the product rather than delegated to a browser prompt.
- Test breadth and feature documentation increased modestly.

### E1 parity / not demonstrated

- Final basic functional correctness was parity in the accepted hidden evaluator.
- Dependency restraint was parity.
- Overall implementation change surface was approximately parity after contamination correction.
- Universal architecture, robustness, or quality superiority was not demonstrated.

### E1 negative signals / historical debt

- Elapsed execution time increased materially in the first pair.
- Hakim did not establish the runnable pre-mutation baseline as explicitly as Control.
- One simplification path lost a useful domain-level validity guard.
- More inspection/tool activity did not produce a higher basic functional score in E1.

T01-T07 add newer bounded evidence showing that several of those failure modes were remediated on the tested POST-E1 set. They do not erase the history.

## Accepted controlled evidence

Pinned behavior surface proven by T06/T07:

- Hakim behavior SHA: `3147203e0c0fadf0237b82cb9ea37f633bc4bab6`
- Claude plugin tree: `fe3ceb770d1b9b082dab802662bc396da8bc3044`

### T06

- corrected E2 Run-002: `TREATMENT_ADVANTAGE`, elapsed `+73.15%`, tool calls `+20.00%`;
- E3 Run-001: `TREATMENT_ADVANTAGE`, elapsed `-4.47%`, tool calls `-41.67%`;
- E4 Run-001: `TREATMENT_ADVANTAGE`, elapsed `+3.21%`, tool calls `-29.17%`;
- median elapsed overhead: `+3.21%` — PASS;
- median tool-call delta: `-29.17%` — PASS;
- accepted functional/correctness regression: none observed.

`POST_E1_T06_ACCEPTANCE = PASS`

Invalid E2 Run-001 remains `INVALID_PAIR` and is not rescored.

### T07

Preserved E2 Run-002 analysis found most of the absolute elapsed delta in residual/unattributed time, so its cause could not be assigned from the available trace:

`T07_C_CLASSIFICATION = CAUSE_NOT_IDENTIFIABLE_FROM_CURRENT_EVIDENCE`

A fresh pre-frozen counterbalanced E2 replication then produced:

- Control elapsed `87.910s`;
- Treatment elapsed `87.917s`;
- Treatment delta approximately `+0.008%` / `+7ms`;
- Control tool calls `20` vs Treatment `11` (`-45%`);
- Control task bookkeeping `9` vs Treatment `0`;
- both visible and hidden functional gates PASS;
- Treatment retained skill-before-mutation and representative-baseline-before-mutation.

The original large E2 slowdown did not reproduce.

`T07_FINAL_DECISION = EFFICIENCY_RECONCILED_NO_CHANGE`

No Hakim product-behavior change was made during T07.

## T08 product-value review

The designed-purpose scorecard classified:

- `PROVEN_ON_TESTED_SET`: 9
- `PARTIAL`: 1
- `NOT_PROVEN`: 0
- `REGRESSED`: 0

The single `PARTIAL` dimension is bounded evidence gathering. The stopping contract is explicit and runtime evidence is positive, but aggregate tool counts do not directly prove that every read/search stopped at exactly the optimal point.

No accepted internal evidence demonstrates a material correctness, safety, product-truth, or execution-efficiency defect that would invalidate a future small controlled real-user evaluation.

The remaining material uncertainties are real-user questions:

- independent developer value/preference;
- inspection sufficiency in naturally messy repositories;
- bounded host/task generalization;
- perceived ceremony/friction versus engineering benefit.

`T08_D_DECISION = PROCEED_TO_BOUNDED_EXTERNAL_EVALUATION`

This means only that such an evaluation is evidence-justified **when separately authorized**.

## POST-E1 acceptance gate

1. [x] Pre-mutation baseline discipline exists and is runtime-proven on the tested set.
2. [x] Bounded evidence-sufficiency stopping behavior exists.
3. [x] Real domain guards are protected from accidental removal.
4. [x] Canonical behavior and maintained host projections remain semantically aligned.
5. [x] Deterministic semantic/runtime regression coverage exists where practical.
6. [x] Repeated controlled experiments show reproducible positive internal value.
7. [x] Accepted correctness/safety does not regress relative to Control.
8. [x] Execution overhead is measured and explicitly reconciled.
9. [x] No user-facing preference claim is made without real-user evidence; independent preference remains an explicitly unresolved future evaluation question.
10. [x] T08 records the explicit post-phase product decision.

`POST_E1_PHASE_DECISION = COMPLETE`

## Authorization boundary after closure

POST-E1 closure does **not** authorize:

- starting an evaluator campaign without a new explicit operator instruction;
- stable `1.0.0`;
- a release tag or GitHub Release;
- registry publication;
- central marketplace/directory promotion;
- broad external evaluator recruitment;
- universal speed, token, cost, ROI, model-quality, safety, or coding-quality claims;
- broad cross-host effectiveness claims beyond accepted evidence.

A future bounded evaluator campaign remains a separate operator-controlled action.

## Final claim boundary

The strongest supported internal statement is:

> On the tested controlled engineering set, the hardened Hakim behavior repeatedly improved the engineering process without observed accepted correctness regression and without a reproducible unacceptable efficiency penalty.

This remains bounded internal evidence, not a universal product-quality or performance claim.
